The National Academies Logo
Research Associateship Programs
Fellowships Office
Policy and Global Affairs

Participating Agencies - AMRMC

  Sign InPrintable View

Opportunity at U.S. Army Medical Research & Materiel Command (AMRMC)

Malaria Immunology


Walter Reed Army Institute of Research, Infectious Diseases-Military Malaria Research Program-Malaria Vaccine Branch

RO# Location
97.15.30.B6759 Silver Spring, MD 20910


Name E-mail Phone
Angov, Evelina 301.319.9614


Emphasis is placed on the development and manufacture of Plasmodium falciparum malaria antigens for testing in human clinical trials at WRAIR and around the world. Studies include identification of optimal presentation of the target antigen to the immune system in order to induce long lasting, protective immunity and to elucidate in vitro correlates of immunity mediated through both humoral and cellular mechanisms. Novel platforms for antigen expression, delivery, and presentation to antigen presenting cells are being explored. Human pathogens are used preferentially to other model parasites whenever feasible. Both erythrocytic and pre-erythrocytic stage antigens are studied. The primary objective is to elucidate protective mechanisms involving antibodies and/or T-cell subsets that mediate cellular effector functions.



Darko CA, et al: Infection and Immunit6y 73(1): 287, 2005

Bergmann-Leitner ES, et al: American Journal of Tropical Medicine and Hygiene 75(3): 437, 2006


Immunity; Antibody specificity; Malaria; P. falciparum; Vaccines; Irbc development; Protein expression; Growth inhibition; Protein folding/structure;


Citizenship:  Open to U.S. citizens, permanent residents and non-U.S. citizens
Level:  Open to Postdoctoral and Senior applicants
Copyright © 2014. National Academy of Sciences. All rights reserved. 500 Fifth St. N.W., Washington, D.C. 20001.
Terms of Use and Privacy Statement.